tiprankstipranks
Akso Health Group Sponsored ADR (DE:8HX)
FRANKFURT:8HX

Akso Health Group Sponsored ADR (8HX) Stock Price & Analysis

0 Followers

8HX Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€0.19 - €2.54
Previous Close€0.69
Volume0.00
Average Volume (3M)650.00
Market Cap
€18.14M
Enterprise Value€18.24M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)N/A
Beta-0.34
Dec 05, 2023
EPS EstimateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding107,217,820
10 Day Avg. Volume0
30 Day Avg. Volume650
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)5.03
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.00%0.01%99.99%
0.00%
Insiders
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors

8HX FAQ

What was Akso Health Group Sponsored ADR’s price range in the past 12 months?
Akso Health Group Sponsored ADR lowest stock price was €0.19 and its highest was €2.54 in the past 12 months.
    What is Akso Health Group Sponsored ADR’s market cap?
    Currently, no data Available
    When is Akso Health Group Sponsored ADR’s upcoming earnings report date?
    Akso Health Group Sponsored ADR’s upcoming earnings report date is Dec 05, 2023 which is 150 days ago.
      How were Akso Health Group Sponsored ADR’s earnings last quarter?
      Currently, no data Available
      Is Akso Health Group Sponsored ADR overvalued?
      According to Wall Street analysts Akso Health Group Sponsored ADR’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Akso Health Group Sponsored ADR pay dividends?
        Akso Health Group Sponsored ADR pays a Notavailable dividend of €1.06 which represents an annual dividend yield of N/A. See more information on Akso Health Group Sponsored ADR dividends here
          What is Akso Health Group Sponsored ADR’s EPS estimate?
          Akso Health Group Sponsored ADR’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Akso Health Group Sponsored ADR have?
          Currently, no data Available
          What happened to Akso Health Group Sponsored ADR’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Akso Health Group Sponsored ADR?
          Currently, no hedge funds are holding shares in DE:8HX
          ---

          Akso Health Group Sponsored ADR Stock Smart Score

          N/A
          Not Ranked
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Negative
          20 days / 200 days
          Momentum
          159.03%
          12-Months-Change

          Fundamentals

          Return on Equity
          -228.89%
          Trailing 12-Months
          Asset Growth
          -19.26%
          Trailing 12-Months

          Company Description

          Akso Health Group Sponsored ADR

          Hexindai Inc. is a holding company, which engages in the operation of online marketplace connecting borrowers and investors. It focuses on facilitating medium-sized credit loans. The company was founded by Xiaobo An in March 2014 and is headquartered in Beijing, China.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Pediatrix Medical Group
          Chemed
          Teladoc
          Akso Health Group Sponsored ADR
          Amedisys
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis